NASDAQ:NTRP - Neurotrope, Inc.
$4.55
 $0.00
0.00%
4:20PM EDT
2019-02-22
Neurotrope, Inc., formerly BlueFlash Communications, Inc., is a biopharmaceutical company with its product candidates in pre-clinical and clinical development. The Company is focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease (AD), which is in the clinical testing stage. Bryostatin, which is a protein kinase C (PKC) Alpha and e activator, is also developed for other neurodegenerative or cognitive diseases and dysfunctions, which are in pre-clinical testing. Its second generation PKC activators, such as the Bryologs are meant for the treatment of central nervous system disorders, lysosomal storage diseases, stroke, cardio protection and traumatic brain injury. It develops Bryostatin-1 for the treatment of Alzheimer's disease along with the rare (Orphan) diseases, such as Fragile X Syndrome and Niemann-Pick Type C. It has completed Phase IIa clinical trials of Bryostatin-1 for the treatment of patients with AD. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  NTRP     avg for
industry  
  avg for
sector  
42 stocks weight:  18. 81   0. 00   0. 00  
42 stocks rank:  3. 64 K 2. 00 K 1. 08 K
# analyst opinions:  2. 00   14. 68   14. 18  

quick ratio:  5. 69   5. 17   1. 75  
current ratio:  6. 41   5. 48   2. 10  

target price low:  4. 77   90. 05   118. 16  
target price avg:  4. 93   115. 98   142. 03  
target price high:  5. 09   141. 44   162. 86  
1-yr high:  11. 43   124. 28   143. 16  
last close:  4. 50   102. 75   129. 63  
50-day avg:  4. 07   98. 90   122. 76  
200-day avg:  7. 52   100. 04   123. 17  
1-yr low:  3. 47   78. 22   100. 14  
volume:  41. 33 K 2. 36 M 4. 94 M
50-day avg volume:  59. 37 K 3. 14 M 4. 85 M
200-day avg volume:  28. 20 K 3. 12 M 4. 26 M

1-day return:  -1. 10 % 1. 74 % 0. 96 %
this week return:  3. 69 % -0. 72 % -0. 25 %
12-wk return:  -23. 99 % 1. 23 % -0. 75 %
52-wk return:  -48. 09 % -2. 03 % 16. 23 %

enterprise value (EV):  24. 58 M 54. 82 B 107. 48 B
market cap:  66. 45 M 47. 12 B 97. 54 B
EBITDA:  -11. 70 M 4. 72 B 7. 18 B
enterprise multiple (EV/EBITDA):  -2. 10   9. 03   16. 84  
total debt:  0. 00   13. 41 B 16. 70 B
net income (common):  -11. 59 M 2. 34 B 3. 61 B

shares outstanding:  12. 92 M 594. 48 M 1. 22 B
shares:  6. 59 M 592. 96 M 1. 15 B
shares short:  53. 23 K 10. 54 M 11. 92 M
shares short prior month:  61. 09 K 11. 90 M 11. 87 M
short ratio:  1. 28   4. 86   3. 18  
short % of float:  0. 73 % 6. 23 % 2. 78 %
total cash/share:  1. 23   11. 99   10. 04  
total cash:  9. 74 M 7. 30 B 7. 05 B
free cash flow:  -4. 63 M 176. 15 M 2. 43 B
operating cash flow:  -8. 91 M 277. 94 M 3. 06 B

book value:  1. 17   15. 06   28. 80  
price/book:  3. 83   -0. 58   -2. 51  
operating margins:  0. 00 % -466. 96 % -635. 17 %
EBITDA margins:  0. 00 % 13. 54 % 22. 51 %
profit margins:  0. 00 % 6. 67 % 10. 02 %
gross margins:  0. 00 % 48. 21 % 54. 28 %

1-yr max volatility:  -23. 03 % --- ---
1-yr mean volatility:  -0. 19 % 0. 01 % 0. 07 %

1-yr EPS:  -1. 47   3. 08   4. 11  
forward EPS:  -1. 59   4. 75   7. 18  
P/E:  -3. 06   15. 54   29. 27  
forward P/E:  -2. 72   -20. 90   3. 33  
PE/G:  0. 24   1. 33   6. 07  
growth:  -12. 72 % 755. 42 % 114. 65 %
earnings high:  -0. 31   1. 33   1. 68  
earnings avg:  -0. 37   0. 97   1. 54  
earnings low:  -0. 43   0. 70   1. 41  
revenue high:  -0. 00   2. 81 B 11. 37 B
revenue avg:  -0. 00   2. 70 B 11. 06 B
revenue low:  -0. 00   2. 61 B 10. 84 B
return on assets:  -48. 59 % -3. 63 % 3. 73 %
return on equity:  -86. 76 % 102. 34 % 26. 90 %

beta (1yr vs S&P500):  0. 45   1. 22   0. 94  
sharpe (1yr):  -0. 81   0. 14   1. 05  

held % insiders:  25. 36 % 6. 40 % 3. 16 %
held % institutions:  26. 80 % 79. 62 % 70. 81 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-22 : NTRP
.    + 0.651 =         0.651 :: INITIAL WEIGHT
.  + 171.464 =       172.116 :: inverse volume-to-price addition
.  + 176.037 =       348.153 :: spline projection addition
.  - 145.192 =       202.961 :: poor performance penalty
.    x 0.717 =       145.614 :: one-year gains+dividend factor
.     x 8.59 =      1250.877 :: 13 weeks' performance factor
.    x 1.478 =      1848.726 :: industry recommendation factor
.    x 0.995 =      1839.743 :: return on assets factor
.    x 0.991 =      1823.782 :: return on equity factor
.    x 2.831 =      5162.328 :: current ratio factor
.    x 1.101 =      5685.792 :: quick ratio factor
.    x 1.335 =      7588.455 :: short ratio factor
.    x 2.038 =      15467.78 :: price-to-book factor
.    x 1.081 =     16721.719 :: 5-day avg > 50-day avg
.    x 2.126 =     35542.122 :: P/E weight
.    x 1.428 =      50740.54 :: PE/G factor
.    x 1.513 =     76761.783 :: beta factor
.    x 0.809 =     62076.988 :: sharpe factor
.    x 1.247 =     77387.221 :: target low factor
.    x 1.103 =     85396.403 :: target mean factor
.    x 1.036 =     88496.286 :: target high factor
.    x 1.012 =     89585.849 :: industry 12-weeks return
.     x 0.99 =      88697.67 :: "drift" penalty 1 days ago
.    x 0.955 =     84745.091 :: "drift" penalty 4 days ago
.    x 0.997 =     84468.004 :: overall "drift" factor
.    x 0.999 =     84383.791 :: largest single-day jump factor
.    x 0.079 =      6654.873 :: low price factor
.      x 1.0 =      6654.183 :: factor hist industry gain for week 07
.   cubeRoot =        18.809 :: reduced for readability
.                     18.809 :: FINAL WEIGHT for NASDAQ:NTRP


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org